Abstract
The philosophy of management of gall bladder cancer ranges from the Japanese aggressive approach (major supra-radical multi-organ resections for advanced disease) at one end to the western pessimistic nihilism (inappropriate management of even early disease) at the other. An Indian “Buddhist” middle path, i.e., aggressive surgical approach towards early (and incidental) gall bladder cancer and non-surgical palliation for advanced gall bladder cancer has been advocated by the author (VKK).
Please also see an Invited Commentary on Philosophy of Management of Gall Bladder Cancer by Hiroaki Shimizu (pp **–**)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chapter References
Agarwal AK, Javed A, Raja K, Sakhuja P. Surgical techniques in the management of primary gall bladder cancer. In: Agarwal A, Fong Y, editors. Carcinoma of the gall bladder. New Delhi: Elsevier; 2014a. p. 106–29.
Agarwal AK, Kalayarasan R, Javed A, Sakhuja P. Role of routine 16b1 lymph node biopsy in the management of gallbladder cancer: an analysis. HPB (Oxford). 2014b;16(3):229–34. https://doi.org/10.1111/hpb.12127. Epub 2013 Jul 22.
Aloia TA, Járufe N, Javle M, Maithel SK, Roa JC, Adsay V, Coimbra FJ, Jarnagin WR. Gallbladder cancer: expert consensus statement. HPB (Oxford). 2015;17(8):681–90. https://doi.org/10.1111/hpb.12444.
Bartlett DL, Fong Y, Fortner JG, Brennan MF, Blumgart LH. Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg. 1996;224(5):639–46.
Beal EW, Lyon E, Kearney J, Wei L, Ethun CG, Black SM, Dillhoff M, Salem A, Weber SM, Tran TB, Poultsides G, Shenoy R, Hatzaras I, Krasnick B, Fields RC, Buttner S, Scoggins CR, Martin RCG, Isom CA, Idrees K, Mogal HD, Shen P, Maithel SK, Pawlik TM, Schmidt CR. Evaluating the American College of Surgeons National Surgical Quality Improvement project risk calculator: results from the U.S. Extrahepatic Biliary Malignancy Consortium. HPB (Oxford). 2017;19(12):1104–11. https://doi.org/10.1016/j.hpb.2017.08.009. Epub 2017 Sep 7.
Beal EW, Mehta R, Tsilimigras DI, Hyer JM, Paredes AZ, Merath K, Dillhoff ME, Cloyd JM, Ejaz A, Pawlik TM. Travel to a high volume hospital to undergo resection of gallbladder cancer: does it impact quality of care and long-term outcomes? HPB (Oxford). 2019; https://doi.org/10.1016/j.hpb.2019.05.004. pii: S1365-182X(19)30543-X.
Benoist S, Panis Y, Fagniez PL. Long-term results after curative resection for carcinoma of the gallbladder. French University Association for Surgical Research. Am J Surg. 1998;175(2):118–22.
Benson AB, D’Angelica MI, Abbott DE, Abrams TA, Alberts SR, Anaya DA, Anders R, Are C, Brown D, Chang DT, Cloyd J, Covey AM, Hawkins W, Iyer R, Jacob R, Karachristos A, Kelley RK, Kim R, Palta M, Park JO, Sahai V, Schefter T, Sicklick JK, Singh G, Sohal D, Stein S, Tian GG, Vauthey JN, Venook AP, Hammond LJ, Darlow SD. Guidelines insights: hepatobiliary cancers, Version 2.2019. J Natl Compr Cancer Netw. 2019;17(4):302–10. https://doi.org/10.6004/jnccn.2019.0019.
Cubertafond P, Gainant A, Cucchiaro G. Surgical treatment of 724 carcinomas of the gallbladder carcinoma: long term results. Ann Surg. 1994;219:275–80.
Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, D’Angelica M, Dematteo RP, Blumgart LH, O’Reilly EM. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008;98(7):485–9. https://doi.org/10.1002/jso.21141.
Ebata T, Nagino M, Nishio H, Arai T, Nimura Y. Right hepatopancreatoduodenectomy: improvements over 23 years to attain acceptability. J Hepatobiliary Pancreat Surg. 2007;14(2):131–5. Epub 2007 Mar 27.
Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y, Nagino M. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients. Ann Surg. 2012;256(2):297–305. https://doi.org/10.1097/SLA.0b013e31826029ca.
Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg. 2000;232(4):557–69.
Glenn F, Hays DM. The scope of radical surgery in the treatment of malignant tumors of the extrahepatic biliary tract. Surg Gynecol Obstet. 1954;99(5):529–41.
Goussous N, Hosseini M, Sill AM, Cunningham SC. Minimally invasive and open gallbladder cancer resections: 30- vs 90-day mortality. Hepatobiliary Pancreat Dis Int. 2017;16(4):405–11. https://doi.org/10.1016/S1499-3872(17)60025-0.
Haga Y, Miyamoto A, Wada Y, Takami Y, Takeuchi H. Value of E-PASS models for predicting postoperative morbidity and mortality in resection of perihilar cholangiocarcinoma and gallbladder carcinoma. HPB (Oxford). 2016;18(3):271–8. https://doi.org/10.1016/j.hpb.2015.09.001. Epub 2015 Nov 18.
Higuchi R, Yamamoto M. Aggressive surgical management and treatment outcomes of gallbladder cancer. In: Agarwal A, Fong Y, editors. Carcinoma of the gall bladder. New Delhi: Elsevier; 2014. p. 175–83.
Higuchi R, Ota T, Araida T, Kajiyama H, Yazawa T, Furukawa T, Yoshikawa T, Takasaki K, Yamamoto M. Surgical approaches to advanced gallbladder cancer: a 40-year single-institution study of prognostic factors and resectability. Ann Surg Oncol. 2014;21(13):4308–16. https://doi.org/10.1245/s10434-014-3885-1. Epub 2014 Jul 15.
Igami T, Ebata T, Yokoyama Y, Sugawara G, Nagino M. Advanced resectable gallbladder cancer: diagnosis and surgical approach. In: Agarwal A, Fong Y, editors. Carcinoma of the gall bladder. New Delhi: Elsevier; 2014. p. 89–105.
Ishihara S, Horiguchi A, Miyakawa S, Endo I, Miyazaki M, Takada T. Biliary tract cancer registry in Japan from 2008 to 2013. J Hepatobiliary Pancreat Sci. 2016;23(3):149–57. https://doi.org/10.1002/jhbp.314. Epub 2016 Jan 26.
Jensen EH, Abraham A, Habermann EB, Al-Refaie WB, Vickers SM, Virnig BA, Tuttle TM. A critical analysis of the surgical management of early-stage gallbladder cancer in the United States. J Gastrointest Surg. 2009;13(4):722–7. https://doi.org/10.1007/s11605-008-0772-8. Epub 2008 Dec 13.
Kaneoka Y, Maeda A, Isogai M. En bloc resection of the hepatoduodenal ligament for advanced biliary malignancy. J Gastrointest Surg. 2015;19(4):708–14. https://doi.org/10.1007/s11605-014-2731-x. Epub 2015 Jan 6.
Kapoor VK. Advanced gallbladder cancer: Indian “middle path”. J Hepatobiliary Pancreat Surg. 2007;14(4):366–73. Epub 2007 Jul 30. PMID:17653634
Kapoor VK, Behari A. Surgical procedures for gall bladder cancer. BAOJ Cancer Res Ther. 2017;3:037.
Kasumova GG, Tabatabaie O, Najarian RM, Callery MP, Ng SC, Bullock AJ, Fisher RA, Tseng JF. Surgical management of gallbladder cancer: simple versus extended cholecystectomy and the role of adjuvant therapy. Ann Surg. 2017;266(4):625–31. https://doi.org/10.1097/SLA.0000000000002385.
Kayahara M, Nagakawa T, Nakagawara H, Kitagawa H, Ohta T. Prognostic factors for gallbladder cancer in Japan. Ann Surg. 2008;248(5):807–14. https://doi.org/10.1097/SLA.0b013e31818a1561.
Kishi Y, Shimada K, Hata S, Oguro S, Sakamoto Y, Nara S, Esaki M, Hiraoka N, Kosuge T. Definition of T3/4 and regional lymph nodes in gallbladder cancer: which is more valid, the UICC or the Japanese staging system? Ann Surg Oncol. 2012;19(11):3567–73. https://doi.org/10.1245/s10434-012-2599-5. Epub 2012 Aug 14.
Kondo S, Nimura Y, Hayakawa N, Kamiya J, Nagino M, Uesaka K. Regional and para-aortic lymphadenectomy in radical surgery for advanced gallbladder carcinoma. Br J Surg. 2000;87(4):418–22.
Kondo S, Nimura Y, Hayakawa N, Kamiya J, Nagino M, Uesaka K. Extensive surgery for carcinoma of the gallbladder. Br J Surg. 2002;89(2):179–84.
Kondo S, Nimura Y, Kamiya J, Nagino M, Kanai M, Uesaka K, Yuasa N, Sano T, Hayakawa N. Factors influencing postoperative hospital mortality and long-term survival after radical resection for stage IV gallbladder carcinoma. World J Surg. 2003;27(3):272–7. Epub 2003 Feb 27.
Lee SE, Kim KS, Kim WB, Kim IG, Nah YW, Ryu DH, Park JS, Yoon MH, Cho JY, Hong TH, et al. Practical guidelines for the surgical treatment of gallbladder cancer. J Korean Med Sci. 2014;29(10):1333–40. https://doi.org/10.3346/jkms.2014.29.10.1333.
Lim H, Seo DW, Park DH, Lee SS, Lee SK, Kim MH, Hwang S. Prognostic factors in patients with gallbladder cancer after surgical resection: analysis of 279 operated patients. J Clin Gastroenterol. 2013;47(5):443–8. https://doi.org/10.1097/MCG.0b013e3182703409.
Mishra PK, Saluja SS, Prithiviraj N, Varshney V, Goel N, Patil N. Predictors of curative resection and long term survival of gallbladder cancer - a retrospective analysis. Am J Surg. 2017;214(2):278–86. https://doi.org/10.1016/j.amjsurg.2017.02.006. Epub 2017 Feb 9.
Miyakawa S, Ishihara S, Horiguchi A, Takada T, Miyazaki M, Nagakawa T. Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan. J Hepatobiliary Pancreat Surg. 2009;16(1):1–7. https://doi.org/10.1007/s00534-008-0015-0. Epub 2008 Dec 26.
Miyazaki M, Yoshitomi H, Miyakawa S, Uesaka K, Unno M, Endo I, Ota T, Ohtsuka M, Kinoshita H, Shimada K, Shimizu H, Tabata M, Chijiiwa K, Nagino M, Hirano S, Wakai T, Wada K, Isayama H, Okusaka T, Tsuyuguchi T, Fujita N, Furuse J, Yamao K, Murakami K, Yamazaki H, Kijima H, Nakanuma Y, Yoshida M, Takayashiki T, Takada T. Clinical practice guidelines for the management of biliary tract cancers 2015: the 2nd English edition. J Hepatobiliary Pancreat Sci. 2015;22(4):249–73. https://doi.org/10.1002/jhbp.233. Epub 2015 Mar 18.
Mizuno T, Ebata T, Yokoyama Y, Igami T, Yamaguchi J, Onoe S, Watanabe N, Ando M, Nagino M. Major hepatectomy with or without pancreatoduodenectomy for advanced gallbladder cancer. Br J Surg. 2019;106(5):626–35. https://doi.org/10.1002/bjs.11088. Epub 2019 Feb 14.
Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Kondo N, Sakabe R, Kobayashi H, Sueda T. Is para-aortic lymph node metastasis a contraindication for radical resection in biliary carcinoma? World J Surg. 2011;35(5):1085–93. https://doi.org/10.1007/s00268-011-1036-4.
Nilsson J, Eriksson S, Nørgaard Larsen P, Keussen I, Christiansen Frevert S, Lindell G, Sturesson C. Concurrent biliary drainage and portal vein embolization in preparation for extended hepatectomy in patients with biliary cancer. Acta Radiol Open. 2015;4(5):2058460115579121. https://doi.org/10.1177/2058460115579121. eCollection 2015 May.
Nishio H, Nagino M, Ebata T, Yokoyama Y, Igami T, Nimura Y. Aggressive surgery for stage IV gallbladder carcinoma; what are the contraindications? J Hepatobiliary Pancreat Surg. 2007;14(4):351–7. Epub 2007 Jul 30.
Ong CT, Leung K, Nussbaum DP, Sun Z, Gloor B, Blazer DG III, Worni M. Open versus laparoscopic portal lymphadenectomy in gallbladder cancer: is there a difference in lymph node yield? HPB (Oxford). 2018;20(6):505–13. https://doi.org/10.1016/j.hpb.2017.10.015. Epub 2018 Feb 19.
Ota T, Araida T, Yamamoto M, Takasaki K. Operative outcome and problems of right hepatic lobectomy with pancreatoduodenectomy for advanced carcinoma of the biliary tract. J Hepatobiliary Pancreat Surg. 2007;14(2):155–8. Epub 2007 Mar 27.
Patkar S, Ostwal V, Ramaswamy A, Engineer R, Chopra S, Shetty N, Dusane R, Shrikhande SV, Goel M. Emerging role of multimodality treatment in gall bladder cancer: outcomes following 510 consecutive resections in a tertiary referral center. J Surg Oncol. 2018;117(3):372–9. https://doi.org/10.1002/jso.24837. Epub 2017 Sep 20.
Sakamoto Y, Nara S, Kishi Y, Esaki M, Shimada K, Kokudo N, Kosuge T. Is extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer? Surgery. 2013;153(6):794–800. https://doi.org/10.1016/j.surg.2012.11.024. Epub 2013 Feb 13.
Sakata J, Kobayashi T, Tajima Y, Ohashi T, Hirose Y, Takano K, Takizawa K, Miura K, Wakai T. Relevance of dissection of the posterior superior pancreaticoduodenal lymph nodes in gallbladder carcinoma. Ann Surg Oncol. 2017;24(9):2474–81. https://doi.org/10.1245/s10434-017-5939-7. Epub 2017 Jun 26.
Shirai Y, Sakata J, Wakai T, Ohashi T, Hatakeyama K. “Extended” radical cholecystectomy for gallbladder cancer: long-term outcomes, indications and limitations. World J Gastroenterol. 2012;18(34):4736–43.
Shukla HS, Sirohi B, Behari A, Sharma A, Majumdar J, Ganguly M, Tewari M, Kumar S, Saini S, Sahni P, Singh T, Kapoor VK, Sucharita V, Kaur T, Shukla DK, Rath GK. Indian Council of Medical Research consensus document for the management of gall bladder cancer. Indian J Med Paediatr Oncol. 2015;36(2):79–84. https://doi.org/10.4103/0971-5851.158829.
Singh SK, Talwar R, Kannan N, Tyagi AK, Jaiswal P, Kumar A. Aggressive surgical approach for gallbladder cancer: a single-center experience from northern India. J Gastrointest Cancer. 2015;46(4):399–407. https://doi.org/10.1007/s12029-015-9766-4.
Tran Cao HS, Zhang Q, Sada YH, Chai C, Curley SA, Massarweh NN. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts. Cancer. 2018;124(1):74–83. https://doi.org/10.1002/cncr.30968. Epub 2017 Aug 25.
Wright BE, Lee CC, Iddings DM, Kavanagh M, Bilchik AJ. Management of T2 gallbladder cancer: are practice patterns consistent with national recommendations? Am J Surg. 2007;194(6):820–5; discussion 825–6.
References for Commentary Notes
Nimura Y, Hayakawa N, Kamiya J, Maeda S, Kondo S, Yasui A, et al. Hepatopancreatoduodenectomy for advanced carcinoma of the biliary tract. Hepatogastroenterology. 1991;38:170–5.
Takasaki K, Kobayashi S, Mutoh H, Akimoto S, Toda K, Asado S, et al. Our experiences (5 cases) of extended right lobectomy combined with pancreato-duodenectomy for the carcinoma of the gall bladder (in Japanese). Tan to Sui. 1980;1:923–32.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Invited Commentary on Philosophy of Management of Gall Bladder Cancer
Invited Commentary on Philosophy of Management of Gall Bladder Cancer
The contents of this chapter include a review of the surgical indications and operative procedures for gallbladder cancer (GBC) (early and advanced stage) in the West and Japan, and clearly show the differences in philosophy and surgical management for GBC between the two. Comparing the two different approaches, the Author (VKK) has established his own philosophy of surgical management (the Indian approach) for GBC, taking good points from each, which seems to be in the middle of Japanese aggressive and Western pessimistic approaches.
The majority of GBC is diagnosed at advanced stage. Surgical complete resection (R0 resection) is the only potentially curative treatment and remains mainstay of management to achieve long-term survival in patients with GBC, but postoperative prognosis is closely correlated with the stage of the disease. In pT1 GBC, lymph node metastasis has almost never been found in Japan; therefore, good prognosis can be achieved even after simple cholecystectomy. As to pT2 GBC, the appropriate surgical strategy can achieve a prognostic improvement, but standard surgical procedure remains controversial in Japan; gallbladder bed resection or resection of liver segments IVA + V (subsegment IVB is called IVA in Japan), and combined with or without extrahepatic bile duct resection for lymph node dissection. There is still no definitive conclusion as to the most preferable surgical procedures for pT2 GBC.
On the other hand, the prognosis is quite poor in pT3 and pT4 GBC, even after complete resection of the tumor. In 1980s, Japanese hepatobiliary surgeons aggressively challenged to perform extended surgical procedures, such as extended right hepatectomy (ERH), hepato-pancreatico-duodenectomy (HPD) or hepato-ligamento-pancreatico-duodenectomy (HLPD) to increase resectability (Takasaki et al. 1980; Nimura et al. 1991). These ultimate procedures carried a high risk of postoperative morbidity and subsequent mortality. In spite of this, very few patients could be cured. Therefore, surgeons in the West have criticized these procedures.
At present, with improvement of surgical techniques and perioperative patient care, including preoperative biliary drainage (PBD) and portal vein embolization (PVE), mortality rate after extended surgical procedures, such as HPD have gradually decreased in Japan. Higher hospital volume is also associated with lower morbidity and mortality rates. However, recent reports have shown still extremely poor survival in patients with locally spreading GBC requiring HPD. The Nagoya group in Japan clearly stated that the indication for HPD for advanced GBC is not recommended from an oncological viewpoint (Mizuno et al. 2019a). That is, advanced GBC requiring HPD, represents technically resectable but oncologically unresectable disease, because of aggressive tumor biology. At present, the role and indication for extended resections such as HPD to achieve complete resection of the tumor in patients with locally spreading GBC should be reconsidered.
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kapoor, V.K. (2021). Philosophy of Management of Gall Bladder Cancer. In: Kapoor, V.K. (eds) A Pictorial Treatise on Gall Bladder Cancer. Springer, Singapore. https://doi.org/10.1007/978-981-15-5289-2_9
Download citation
DOI: https://doi.org/10.1007/978-981-15-5289-2_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-5288-5
Online ISBN: 978-981-15-5289-2
eBook Packages: MedicineMedicine (R0)